- In march 2024, Avenacy launched Furosemide for Injection in the U.S. market. This product is available in packs of 25 units, each containing 100 mg/10 mL doses. The company emphasizes patient safety and streamlined care through its differentiated packaging and labeling.
Frequently Asked Questions
Pfizer Inc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (U.S.), Fresenius Kabi AG (Germany), Hikma Pharmaceuticals PLC (U.K.), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), Bristol Myers Squibb Company (U.S.) GSK Plc. (U.K.), Bayer AG (Germany), Aurobindo Pharma (India) are the major companies in the Diuretic Drugs market.
In March 2024, Avenacy launched Furosemide for Injection in the U.S. market. This product is available in packs of 25 units, each containing 100 mg/10 mL doses. The company emphasizes patient safety and streamlined care through its differentiated packaging and labeling.
The countries covered in the busway market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.